Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
9.36
+0.92 (10.90%)
At close: Aug 4, 2025, 4:00 PM
9.38
+0.02 (0.21%)
After-hours: Aug 4, 2025, 7:53 PM EDT
Elevation Oncology Market Cap
Mind Medicine (MindMed) has a market cap or net worth of $712.18 million as of August 4, 2025. Its market cap has increased by 18.10% in one year.
Market Cap
712.18M
Enterprise Value
570.38M
1-Year Change
18.10%
Ranking
Category
Stock Price
$9.36
Market Cap Chart
Since March 4, 2020, Mind Medicine (MindMed)'s market cap has increased from $595.37M to $712.18M, an increase of 19.62%. That is a compound annual growth rate of 3.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 642.18M | 25.82% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | 3.45B | 479.23% |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |